Felbamate
NDC 53746-734, Felbamate, tablet, from Amneal Pharmaceuticals of New York LLC.
- Product NDC
- 53746-734
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA201680
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/53746-734 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FELBAMATE400 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 53746-734-30 | 53746073430 | 30 TABLET in 1 BOTTLE (53746-734-30) |
| 53746-734-90 | 53746073490 | 90 TABLET in 1 BOTTLE (53746-734-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1aa40de5-c02d-49d6-8722-ed88c40c3ba6NADAC price for package 53746073490
GET /v1/drugs/nadac/53746073490
Use it
Look up 53746-734 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/53746-734 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 53746-734. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.